Regeneron’s star bispecific is linked to 2 deaths in a small study — which was no help for its Q1 call

Regeneron execs chose to disclose in their Q1 call with analysts today that their closely watched bispecific REGN1979 was linked with two deaths from cytokine release syndrome in a small study involving 30 patients.